NEWS

  • NEWSLETTER ARCHIVE

    Click HERE to get the most recent edition of the MPN Update newsletter! 2021 Fall  |  Summer  |  Spring 2020 Fall  |  Summer  |  Spring 2019 Fall  |  Spring 2018 Fall  |  Spring 2017 Fall  |  Spring 2016 Fall  |  Spring 2015 Fall  |  Spring 2014 Fall  |  Spring 2013 Fall  |  Spring 2012 Fall  |  Spring 2011 Fall  |  Spring 2010 Fall  |  Spring 2009 Fall  |  Spring 2008 Fall  |  Spring 2007 Fall  |  Spring 2006 Fall  |  Spring 2005 Summer  |  Spring 2004 Fall  |  Summer   … Read More »NEWSLETTER ARCHIVE

    READ MORE

    Help Advance Myeloproliferative Neoplasms (MPN) Research from Home and Earn $100

    The MPN Research Foundation is reaching out to the MPN patient community to raise awareness about an opportunity for patients 18 years of age or older with Myeloproliferative Neoplasms (MPN). Patients who qualify can support research by providing a one-time blood donation from home. The blood sample will be collected by a mobile medical professional… Read More »Help Advance Myeloproliferative Neoplasms (MPN) Research from Home and Earn $100

    READ MORE

    I5 WEEKS AFTER HEALTH COLLAPSE, COACH BACK IN BELOVED ROUTINE

    Joe WilliamsSentinel Staff Writer March 19, 2006 EUSTIS — The sounds of baseball were all around Chet Lemon and it was music to his ears. The repeated thwack of metal-alloy bats striking baseballs during batting practice rang out. The chatter of coaches and players, working on bunt coverage and pickoff plays, filled the air. “I… Read More »I5 WEEKS AFTER HEALTH COLLAPSE, COACH BACK IN BELOVED ROUTINE

    READ MORE

    BIKE RIDE FUND-RAISER IN MEMORY OF BELMONT CYCLIST

    Thursday, July 20, 2006 Belmont resident Al Bolea lost his gallant seven-year fight against myelofibrosis at age 47. Bolea was a member of the Charles River Wheelmen (CRW) cycling club. Riding on his own, he dominated the hills on rides throughout Massachusetts and New England. Yet as a leader of CRW’s Wednesday night ride throughout… Read More »BIKE RIDE FUND-RAISER IN MEMORY OF BELMONT CYCLIST

    READ MORE

    MPD FOUNDATION PRESIDENT, BOB ROSEN, ATTENDS 2004 ASH CONFERENCE IN SAN DIEGO, CALIFORNIA

    I attended the Saturday sessions of the ASH conference in San Diego and wanted to make a brief report of my impressions. It was held in the beautiful convention center on the San Diego waterfront and it seemed like the turnout was huge, in the many thousands. One of the MPD Sessions, in a room… Read More »MPD FOUNDATION PRESIDENT, BOB ROSEN, ATTENDS 2004 ASH CONFERENCE IN SAN DIEGO, CALIFORNIA

    READ MORE

    LETTER FROM THE PRESIDENT

    Summer, 2004 I can’t believe it’s been five years since we started the MPD Foundation. Lately I have been reflecting on all we have done since our inception: raising money, building a volunteer staff, funding scientific research, and building a nationwide and worldwide community of people with similar interests. The question in all of our… Read More »LETTER FROM THE PRESIDENT

    READ MORE

    INCYTE NEARS THE FINISH LINE FOR FIRST FDA APPROVED TREATMENT FOR MYELOFIBROSIS

    June 2011 During ASCO’s annual meeting Incyte announced that it has submitted a New Drug Application (NDA) for Ruxolitinib to the US Food and Drug Administration. They have requested a Priority Review of the application. Ruxolitinib is the first JAK1/JAK2 inhibitor to near commercialization and is now being investigated in other hematology conditions. It is… Read More »INCYTE NEARS THE FINISH LINE FOR FIRST FDA APPROVED TREATMENT FOR MYELOFIBROSIS

    READ MORE

    MPN RESEARCH PAYS OFF AS NEW MPN DRUGS ADVANCE TO MARKET: A REPORT FROM ASCO

    June 2011 June’s American Society of Clinical Oncology (ASCO) conference in Chicago demonstrated that investments in MPN Research are starting to pay off as multiple drugs move through the drug development pipeline. Walking the halls of McCormick one could not help but be struck by strong notes of excitement and optimism. Discoveries related to melanoma,… Read More »MPN RESEARCH PAYS OFF AS NEW MPN DRUGS ADVANCE TO MARKET: A REPORT FROM ASCO

    READ MORE

    PATIENTS PUSH RESEARCHERS TO SHARE DATA

    March 2011 The patients who run the MPD Foundation are impatient to see results from the medical research they fund. That’s understandable: their rare blood diseases – essential thrombocythemia, polycythemia vera and myelofibrosis, collectively called myeloproliferative neoplasms – are progressive, incurable and generally not well managed by existing medicines. So, in its latest round of… Read More »PATIENTS PUSH RESEARCHERS TO SHARE DATA

    READ MORE

    EUROPEAN JOURNAL OFFERS REVIEW OF CURRENT JAK INHIBITORS

    April 2011 The Belgian Journal of Hematology recently published their review of the state of JAK Inhibitors. Since its discovery in 2005 several companies have been working on creating a JAK Inhibitor for treatment of the myeloproliferative neoplasms. Click here to read the full article (PDF) Current trials for polycythemia vera, essential thrombocythemia and myelofibrosis… Read More »EUROPEAN JOURNAL OFFERS REVIEW OF CURRENT JAK INHIBITORS

    READ MORE

    1 2 3 37
  • Get updates on MPN patients and research breakthroughs.
    What are the latest developments in MPN Research?